MARIA VILLASENOR: Open Payments
NPI 1811646284 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$827 in 32 payments from 11 companies in 2025. Trend: 2023 $296 · 2024 $726 · 2025 $827
Food & beverage: $827
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $388 |
| Merck Sharp & Dohme LLC | 5 | $95 |
| SCPHARMACEUTICALS INC. | 3 | $59 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $56 |
| E.R. Squibb & Sons, L.L.C. | 2 | $40 |
| Kestra Medical Technology Services, Inc. | 2 | $40 |
| Olympus America Inc. | 1 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $33 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
Products named: JARDIANCE, VERQUVO, FUROSCIX, Kerendia, ELIQUIS, Assure WCD, iTIND System, LifeVest.
Industry payments across IL — which companies pay providers there.
